Oncotarget

Research Papers:

Hypoxia-regulated gene expression explains differences between melanoma cell line-derived xenografts and patient-derived xenografts

Joydeep Bhadury _, Berglind O. Einarsdottir, Agnieszka Podraza, Roger Olofsson Bagge, Ulrika Stierner, Lars Ny, Marcela Dávila López and Jonas A. Nilsson

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:23801-23811. https://doi.org/10.18632/oncotarget.8181

Metrics: PDF 711 views  |   HTML 1073 views  |   ?  


Abstract

Joydeep Bhadury1, Berglind O. Einarsdottir1, Agnieszka Podraza1, Roger Olofsson Bagge1, Ulrika Stierner2, Lars Ny2, Marcela Dávila López3, Jonas A. Nilsson1

1Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden

2Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden

3The Bioinformatics Core Facility at the University of Gothenburg, Gothenburg, Sweden

Correspondence to:

Joydeep Bhadury, e-mail: joydeep.bhadury@gu.se

Jonas A. Nilsson, e-mail: jonas.a.nilsson@surgery.gu.se

Keywords: melanoma, miR210, hypoxia, xenografts, MEK inhibitor

Received: January 25, 2016     Accepted: March 04, 2016     Published: March 18, 2016

ABSTRACT

Cell line-derived xenografts (CDXs) are an integral part of drug efficacy testing during development of new pharmaceuticals against cancer but their accuracy in predicting clinical responses in patients have been debated. Patient-derived xenografts (PDXs) are thought to be more useful for predictive biomarker identification for targeted therapies, including in metastatic melanoma, due to their similarities to human disease. Here, tumor biopsies from fifteen patients and ten widely-used melanoma cell lines were transplanted into immunocompromised mice to generate PDXs and CDXs, respectively. Gene expression profiles generated from the tumors of these PDXs and CDXs clustered into distinct groups, despite similar mutational signatures. Hypoxia-induced gene signatures and overexpression of the hypoxia-regulated miRNA hsa-miR-210 characterized CDXs. Inhibition of hsa-miR-210 with decoys had little phenotypic effect in vitro but reduced sensitivity to MEK1/2 inhibition in vivo, suggesting down-regulation of this miRNA could result in development of resistance to MEK inhibitors.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 8181